259 related articles for article (PubMed ID: 24048401)
1. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
Maric NP; Adzic M
Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
[TBL] [Abstract][Full Text] [Related]
2. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
3. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B
Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
[TBL] [Abstract][Full Text] [Related]
4. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
5. [The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression].
Juruena MF; Cleare AJ; Pariante CM
Braz J Psychiatry; 2004 Sep; 26(3):189-201. PubMed ID: 15645065
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptors in depression.
Pariante CM; Nemeroff CB; Miller AH
Isr J Med Sci; 1995 Dec; 31(12):705-12. PubMed ID: 8543464
[TBL] [Abstract][Full Text] [Related]
7. Novel agents in development for the treatment of depression.
Grady MM; Stahl SM
CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
[TBL] [Abstract][Full Text] [Related]
8. Widespread hypothalamic-pituitary-adrenocortical axis-relevant and mood-relevant effects of chronic fluoxetine treatment on glucocorticoid receptor gene expression in mice.
Heydendael W; Jacobson L
Eur J Neurosci; 2010 Mar; 31(5):892-902. PubMed ID: 20374287
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.
Pariante CM
Ann N Y Acad Sci; 2009 Oct; 1179():144-52. PubMed ID: 19906237
[TBL] [Abstract][Full Text] [Related]
10. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
11. The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats.
Szymańska M; Budziszewska B; Jaworska-Feil L; Basta-Kaim A; Kubera M; Leśkiewicz M; Regulska M; Lasoń W
Psychoneuroendocrinology; 2009 Jul; 34(6):822-32. PubMed ID: 19195790
[TBL] [Abstract][Full Text] [Related]
12. The effects of antidepressants on the hypothalamic-pituitary-adrenal axis.
Mason BL; Pariante CM
Drug News Perspect; 2006 Dec; 19(10):603-8. PubMed ID: 17299602
[TBL] [Abstract][Full Text] [Related]
13. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
Barden N
J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C
J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
[TBL] [Abstract][Full Text] [Related]
15. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
[TBL] [Abstract][Full Text] [Related]
16. The design of new antidepressants: can formal models help? A first attempt using a model of the hippocampal control over the HPA-axis based on a review from the literature.
Belzung C; Billette de Villemeur E
Behav Pharmacol; 2010 Dec; 21(8):677-89. PubMed ID: 21051994
[TBL] [Abstract][Full Text] [Related]
17. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
Twardowska K; Rybakowski J
Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
[TBL] [Abstract][Full Text] [Related]
18. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
Cubała WJ; Landowski J
Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
[TBL] [Abstract][Full Text] [Related]
19. Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders.
Terrón JA
Rev Neurosci; 2014; 25(3):439-49. PubMed ID: 24663228
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression.
Schüle C; Baghai TC; Eser D; Rupprecht R
Expert Rev Neurother; 2009 Jul; 9(7):1005-19. PubMed ID: 19589050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
